Korean J Urol.
1987 Feb;28(1):74-78.
M-VAC Combination Chemotherapy in Advanced Bladder Cancer
- Affiliations
-
- 1Keimyung University, School of Medicine, Taegu, Korea.
Abstract
- Patients with advanced carcinoma of the bladder that relapses or persists after conventional therapy have a poor prognosis. The management of the patient with recurrent local or disseminated bladder cancer presents a difficult clinical problem. In l985, Sternberg et al reported 7l% significant tumor regression and 50% complete clinical remission with M-VAC(Methotrexate, Vinblastin, Adriamycin and Cisplatin) combination chemotherapy for treatment of advanced bladder carcinoma Herein, we report 4 cases of M-VAC combination chemotherapy in far advanced bladder carcinoma with had measurable metastatic lesions enough to evaluate the objective response of chemotherapy.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- M-VAC and MAC Combination Chemotherapy in Advanced Bladder Cancer
- Adjuvant M-VAC Chemotherapy in Locally Advanced Bladder Cancer
- Preliminary Results of Neoadjuvant M-VAC(Methotrexate, Vinblastine, Adriamycin, Cisplatin) Chemotherapy for Bladder Carcinoma
- CISCA Combination Chemotherapy in Advanced Bladder Cancer
- M-VAC Monotherapy for Advanced Transitional Cell Carcinoma of the Bladder
